Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Comic: Vaccine Rollout, Fed Meeting To Drive Sentiment In The Week Ahead

Published 12/12/2020, 10:02 PM
Updated 12/12/2020, 10:05 PM
© Investing.com

© Investing.com

By Jesse Cohen

Investing.com - Stocks fell on Friday to wrap up a losing week, but Wall Street’s major indexes stayed near their recent record highs amid ongoing optimism over Covid-19 vaccine progress.

The S&P 500 declined 0.1% to end the day at 3,683, the Nasdaq Composite shed 0.2% to settle at 12,377, while the small-cap Russell 2000 dipped 0.6% to finish the session at 1,910.

The Dow Jones Industrial Average meanwhile eked out a gain of 47 points, or 0.2%, to end at 30,046.

Both the Dow and S&P 500 posted their first weekly declines in three weeks, losing 0.6% and 1%, respectively. The tech-heavy Nasdaq suffered a loss of 0.7% over that time frame, however the Russell 2000 scored its sixth straight weekly gain, rising 1%.

Investors will be watching fresh vaccine developments in the week ahead.

The U.S. Food and Drug Administration on Friday granted an emergency use authorization of Pfizer (NYSE:PFE)'s COVID-19 vaccine}}, developed with German partner BioNTech (NASDAQ:{{1152992|BNTX).

The U.S. government has said it will begin distributing the vaccine around the country immediately, with the first inoculations expected within days.

Markets will also be paying close attention to the outcome of the Federal Reserve’s all-important policy meeting on Wednesday, with market experts split on whether it will tweak its $80 billion monthly bond-buying program.

There is also key November retail sales data, as well as the latest batch of Markit Purchase Manager Indexes and regional Fed surveys due in the week ahead.

Meanwhile, in earnings, there are just a few notable companies reporting their latest financial results, including Nike (NYSE:NKE), and FedEx (NYSE:FDX).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.